Recapping some of the most talked-about news this week from the nation and around the world – in case you missed it.

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Regeneron Pharmaceuticals has announced plans to acquire the genetic testing company 23andMe for $256 million, with a clear ...

Alert: Your DNA Is At Risk in This New Age of Increased Surveillance** The recent sale of the genetic data company 23andMe to Regeneron Pharmaceuticals has raised significant concerns about the ...

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...